Long-term lithium therapy and risk of chronic kidney disease, hyperparathyroidism and hypercalcemia: a cohort study

Azab AN, Shnaider A, Osher Y, Wang D, Bersudsky Y, Belmaker RH. Lithium nephrotoxicity. Int J Bipolar Disord. 2015;3(1):13.

Article  Google Scholar 

Ballehaninna UK, Nguyen SM, Chamberlain RS. Lithium associated hyperparathyroidism: an evidence based surgical approach. SS. 2011;02(10):468–75.

Article  Google Scholar 

Batlle DC, von Riotte AB, Gaviria M, Grupp M. Amelioration of polyuria by amiloride in patients receiving long-term lithium therapy. N Engl J Med. 1985;312(7):408–14.

Article  CAS  Google Scholar 

Bedford JJ, Weggery S, Ellis G, McDonald FJ, Joyce PR, Leader JP, et al. Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride. CJASN. 2008;3(5):1324–31.

Article  CAS  Google Scholar 

Bockenhauer D, Bichet DG. Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus. Nat Rev Nephrol. 2015;11(10):576–88.

Article  CAS  Google Scholar 

Clos S, Rauchhaus P, Severn A, Cochrane L, Donnan PT. Long-term effect of lithium maintenance therapy on estimated glomerular filtration rate in patients with affective disorders: a population-based cohort study. Lancet Psychiatry. 2015;2(12):1075–83.

Article  Google Scholar 

Fogo AB, Lusco MA, Andeen NK, Najafian B, Alpers CE. AJKD atlas of renal pathology: lithium nephrotoxicity. Am J Kidney Dis. 2017;69(1):e1-2.

Article  Google Scholar 

Geddes JR, Miklowitz DJ. Treatment of bipolar disorder. Lancet. 2013;381(9878):1672–82.

Article  CAS  Google Scholar 

Gitlin M. Lithium side effects and toxicity: prevalence and management strategies. Int J Bipolar Disord. 2016;4(1):27.

Article  Google Scholar 

Glassock RJ, Rule AD. Aging and the kidneys: anatomy, physiology and consequences for defining chronic kidney disease. Nephron. 2016;134(1):25–9.

Article  Google Scholar 

Goodwin G, Haddad P, Ferrier I, Aronson J, Barnes T, Cipriani A, et al. Evidence based guidelines for treating bipolar disorder: revised third edition recommendations from the British association for psychopharmacology. J Psychopharmacol. 2016;30(6):495–553.

Article  CAS  Google Scholar 

Gupta S, Khastgir U. Drug information update. lithium and chronic kidney disease: debates and dilemmas. BJPsych Bull. 2017;41(4):216–20.

Article  Google Scholar 

Hetmar O, Bolwig TG, Brun C, Ladefoged J, Larsen S, Rafaelsen OJ. Lithium: long-term effects on the kidney I. renal function in retrospect. Acta Psychiatr Scand. 1986;73(5):574–81.

Article  CAS  Google Scholar 

Khairallah W, Fawaz A, Brown EM, El-Hajj FG. Hypercalcemia and diabetes insipidus in a patient previously treated with lithium. Nat Rev Nephrol. 2007;3(7):397–404.

Article  Google Scholar 

Kortenoeven MLA, Fenton RA. Renal aquaporins and water balance disorders. Biochim Biophys Acta. 2014;1840(5):1533–49.

Article  CAS  Google Scholar 

Kortenoeven MLA, Li Y, Shaw S, Gaeggeler H-P, Rossier BC, Wetzels JFM, et al. Amiloride blocks lithium entry through the sodium channel thereby attenuating the resultant nephrogenic diabetes insipidus. Kidney Int. 2009;76(1):44–53.

Article  CAS  Google Scholar 

Kripalani M, Shawcross J, Reilly J, Main J. Lithium and chronic kidney disease. BMJ. 2009;339(jul03 1):b2452–b2452.

Article  Google Scholar 

Kwiatkowska E, Domański L, Dziedziejko V, Kajdy A, Stefańska K, Kwiatkowski S. The mechanism of drug nephrotoxicity and the methods for preventing kidney damage. IJMS. 2021;22(11):6109.

Article  CAS  Google Scholar 

Lehmann SW, Lee J. Lithium-associated hypercalcemia and hyperparathyroidism in the elderly: what do we know? J Affect Disord. 2013;146(2):151–7.

Article  CAS  Google Scholar 

Leucht S, Helfer B, Dold M, Kissling W, McGrath JJ. Lithium for schizophrenia. cochrane schizophrenia group, editor. Cochrane Database Syst Rev. 2015;2015:10. https://doi.org/10.1002/14651858.CD003834.pub3.

Article  Google Scholar 

McHenry CR, Lee K. Lithium therapy and disorders of the parathyroid glands. Endocr Pract. 1996;2(2):103–9.

Article  CAS  Google Scholar 

Mifsud S, Cilia K, Mifsud EL, Gruppetta M. Lithium-associated hyperparathyroidism. Br J Hosp Med. 2020;81(11):1–9.

Article  Google Scholar 

Mody H, Ramakrishnan V, Chaar M, Lezeau J, Rump A, Taha K, et al. A review on drug-induced nephrotoxicity: pathophysiological mechanisms, drug classes, clinical management, and recent advances in mathematical modeling and simulation approaches. Clin Pharmacol Drug Dev. 2020;9(8):896–909.

Article  CAS  Google Scholar 

Morriss R, Benjamin B. Lithium and eGFR: a new routinely available tool for the prevention of chronic kidney disease. Br J Psychiatry. 2008;193(2):93–5.

Article  Google Scholar 

Nankivell BJ. Abnormal laboratory results: creatinine clearance and the assessment of renal function. Aust Prescr. 2001;24(1):15–7.

Article  Google Scholar 

Ng F, Mammen OK, Wilting I, Sachs GS, Ferrier IN, Cassidy F, et al. the international society for bipolar disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. Bipolar Disord. 2009;11(6):559–95.

Article  CAS  Google Scholar 

Nordenström J, Strigård K, Perbeck L, Willems J, Bågedahl-Strindlund M, Linder J. Hyperparathyroidism associated with treatment of manic-depressive disorders by lithium. Eur J Surg. 1992;158(4):207–11.

Google Scholar 

Pahwa M, Joseph B, Nunez NA, Jenkins GD, Colby CL, Kashani KB, et al. Long-term lithium therapy and risk of chronic kidney disease in bipolar disorder: a historical cohort study. Bipolar Disord. 2021;23(7):715–23.

Article  CAS  Google Scholar 

Perazella MA. Pharmacology behind common drug nephrotoxicities. CJASN. 2018;13(12):1897–908.

Article  CAS  Google Scholar 

Perazella MA, Rosner MH. Drug-induced acute kidney. Injury. 2022. https://doi.org/10.2215/CJN.11290821.

Article  Google Scholar 

Presne C, Fakhouri F, Noël L-H, Stengel B, Even C, Kreis H, et al. Lithium-induced nephropathy: rate of progression and prognostic factors. Kidney Int. 2003;64(2):585–92.

Article  CAS  Google Scholar 

Rej S, Herrmann N, Shulman K. The effects of lithium on renal function in older adults—a systematic review. J Geriatr Psychiatry Neurol. 2012;25(1):51–61.

Article  Google Scholar 

Schmitt R, Melk A. Molecular mechanisms of renal aging. Kidney Int. 2017;92(3):569–79.

Article  CAS  Google Scholar 

Shine B, McKnight RF, Leaver L, Geddes JR. Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data. Lancet. 2015;386(9992):461–8.

Article  CAS  Google Scholar 

Szalat A, Mazeh H, Freund HR. Lithium-associated hyperparathyroidism: report of four cases and review of the literature. Eur J Endocrinol. 2009;160(2):317–23.

Article  CAS  Google Scholar 

Tees Esk and Wear Valley NHS Foundation Trust. Guidelines on safe lithium prescribing and shared care. 2021. https://www.tewv.nhs.uk/content/uploads/2022/01/Lithium-Shared-Care-Guidelines.pdf?UNLID=98991256620224215212

Timmer RT, Sands JM. Lithium intoxication. JASN. 1999;10(3):666–74.

Article  CAS  Google Scholar 

Vázquez GH, Bahji A, Undurraga J, Tondo L, Baldessarini RJ. Efficacy and tolerability of combination treatments for major depression: antidepressants plus second-generation antipsychotics vs esketamine vs lithium. J Psychopharmacol. 2021;35(8):890–900.

Article  Google Scholar 

Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, et al. Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20(2):97–170.

Article  Google Scholar 

留言 (0)

沒有登入
gif